Unchained Labs Unveils Groundbreaking AI Developability Workcell
In a significant advancement for life sciences, Unchained Labs has introduced its latest innovation, the
AI Developability Workcell. Launched on September 8, 2026, this cutting-edge system is designed specifically for biologics researchers, providing an integrated solution that combines automation, sample preparation, analytics, and artificial intelligence into one cohesive platform.
The Challenge of Developability Screening
Historically, developability screening has been a cumbersome process rife with inefficiencies. Researchers must navigate multiple tools and software systems while juggling numerous samples, often leading to a fragmented workflow that complicates data analysis. Manual handling of samples and the need to transfer data from various sources leaves scientists with a chaotic experience, spending valuable time trying to determine which candidates warrant further investment of their resources.
A Revolutionary Solution: The AI Developability Workcell
The AI Developability Workcell aims to fundamentally change this outdated paradigm. Utilizing the
Stuntman automation platform, it features a suite of tools, including
Stunner,
Aunty, and
Lil' Tuna, all integrated onto Stuntman’s deck. This combination enables researchers to conduct developability experiments seamlessly. Specifically, the Workcell allows for:
- - Rapid Screening: Researchers can swiftly process plates containing biologic candidates without the usual logistical hurdles.
- - Comprehensive Analytics: The system measures key parameters such as concentration, size, polydispersity, and aggregation (via Stunner), evaluates thermal and colloidal stability (using Aunty), and manages sample concentration and buffer exchange (through Lil' Tuna).
- - Data Integration: Stuntman orchestrates the experiments, automatically connecting all gathered data. The native AI capabilities of the Workcell allow researchers to easily compare candidates and make informed decisions without the need for extensive data hunting across separate software platforms.
Beyond these features, users have additional options to introduce pH adjustments, visual inspections, stress testing, and other off-deck analytics to refine their studies even further. This holistic approach ensures that research teams can efficiently navigate the complexities of biologics development.
Embracing the Future of Biologics Research
Tim Harkness, Founder and CEO of Unchained Labs, articulated the need for such a system: "Developability research has been stuck in the past — samples moving from tool to tool, data trapped in different software, and scientists left to piece together the answer. The AI Developability Workcell changes all of that. Automation, sample prep, analytics, and AI work together from day one — so teams can ditch the chaos and start advancing the right candidates in days instead of weeks."
With the launch of the AI Developability Workcell, Unchained Labs is not just promoting a new product but advocating for a new vision in biologics research. By eliminating the tedious aspects of sample management and data analysis, the Workcell empowers researchers to focus on innovation and discovery.
About Unchained Labs
Headquartered in
Pleasanton, California, Unchained Labs focuses on providing innovative, AI-native tools tailored for the life sciences sector. Through its commitment to improving research tools and capabilities, Unchained Labs aims to facilitate the advancement of biologics and gene therapies, helping researchers achieve more significant outcomes with less hassle. For further information, visit
www.unchainedlabs.com.
Media Contact:
Krystin Schmidt
VP Marketing, Unchained Labs
Email: [email protected]
Phone: 925.392.5597